NOVAVAX INC — Director's Dealing 2015

Mar 9, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2015-03-05

Reporting Person: Erck Stanley C (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-05	Stock Option (Right to buy)	$8.94	A	900000	Acquired	2025-03-05	Common Stock (900000)	Direct

Footnotes

F1: This option grant was approved by a committee of Novavax's board of directors on March 5, 2015, subject to shareholder approval of the Novavax, Inc. 2015 Stock Incentive Plan.

F2: The option vests in four equal annual installments beginning on the first anniversary of the date of grant.